New York State Common Retirement Fund’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,900
| Closed | -$237K | – | 3323 |
|
|
2020
Q4 | $237K | Hold |
12,900
| – | – | ﹤0.01% | 2687 |
|
|
2020
Q3 | $237K | Hold |
12,900
| – | – | ﹤0.01% | 2569 |
|
|
2020
Q2 | $193K | Hold |
12,900
| – | – | ﹤0.01% | 2658 |
|
|
2020
Q1 | $204K | Hold |
12,900
| – | – | ﹤0.01% | 2449 |
|
|
2019
Q4 | $209K | Hold |
12,900
| – | – | ﹤0.01% | 2721 |
|
|
2019
Q3 | $192K | Hold |
12,900
| – | – | ﹤0.01% | 2793 |
|
|
2019
Q2 | $213K | Hold |
12,900
| – | – | ﹤0.01% | 2786 |
|
|
2019
Q1 | $223K | Hold |
12,900
| – | – | ﹤0.01% | 2673 |
|
|
2018
Q4 | $228K | Hold |
12,900
| – | – | ﹤0.01% | 2652 |
|
|
2018
Q3 | $234K | Hold |
12,900
| – | – | ﹤0.01% | 2762 |
|
|
2018
Q2 | $252K | Buy |
+12,900
| New | +$242K | ﹤0.01% | 2775 |
|
|
2017
Q2 | – | Sell |
-11,407
| Closed | -$135K | – | 3273 |
|
|
2017
Q1 | $135K | Buy |
11,407
+1
| +0% | +$12 | ﹤0.01% | 2896 |
|
|
2016
Q4 | $149K | Hold |
11,406
| – | – | ﹤0.01% | 2870 |
|
|
2016
Q3 | $165K | Buy |
11,406
+2,406
| +27% | +$34.2K | ﹤0.01% | 2826 |
|
|
2016
Q2 | $108K | Hold |
9,000
| – | – | ﹤0.01% | 2962 |
|
|
2016
Q1 | $168K | Hold |
9,000
| – | – | ﹤0.01% | 2751 |
|
|
2015
Q4 | $193K | Hold |
9,000
| – | – | ﹤0.01% | 2790 |
|
|
2015
Q3 | $152K | Buy |
9,000
+2,670
| +42% | +$66.4K | ﹤0.01% | 2907 |
|
|
2015
Q2 | $237K | Buy |
+6,330
| New | +$204K | ﹤0.01% | 2859 |
|
New York State Common Retirement Fund's CBMG Position: Q1 2021 in Review
New York State Common Retirement Fund sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 12,900 shares — an estimated $237K sold.
New York State Common Retirement Fund first reported a position in CBMG in Q2 2015 and held it in 19 quarters. The position peaked at $252K in Q2 2018. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.
- New York State Common Retirement Fund reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
- New York State Common Retirement Fund sold 12,900 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $237K.
- New York State Common Retirement Fund first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and held it in 19 quarters.
- New York State Common Retirement Fund's Cellular Biomedicine Group, Inc. position peaked at $252K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.
Based on New York State Common Retirement Fund's 13F filing for Q1 2021, filed 11 May 2021.